Please provide your email address to receive an email when new articles are posted on . Among patients who underwent a stress myocardial perfusion PET scan, increasing magnitude of stress myocardial ...
The significantly longer half-life of Flyrcado (109 minutes) allows for it to be manufactured at an offisite pharmacy and delivered as a ready-to-use unit dose. The Food and Drug Administration (FDA) ...
-- Company’s Novel Imaging Agents in Development for Evaluation of Coronary Artery Disease and Heart Failure to be Featured in 14 Presentations -- “The amount of data on two of our PET cardiac imaging ...
GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients with known or suspected coronary artery disease (CAD), compared to SPECT MPI, ...
Researchers from the Mayo Clinic have reported findings from the preclinical evaluation of a novel cardiac targeting peptide (CTP)-based radiotracer – [68Ga]NOTA-CTP – being developed as a myocardial ...
The emerging advantages of positron-emission tomography (PET) myocardial perfusion imaging (MPI) for coronary artery disease (CAD) diagnosis and assessment of cardiovascular event risk has prompted ...
Researchers developed an AI model to detect myocardial ischemia and coronary microvascular and vasomotor dysfunction using ...
GE HealthCare GEHC recently unveiled new advancements in precision cardiac care at the 2025 SNMMI annual meeting in New Orleans, with a spotlight on Flyrcado—its FDA-approved Positron Emission ...
Photo Credit: Adapted from de Winter RW, et al. EuroIntervention. 2021;Epub ahead of print. Used with permission. Remote myocardial perfusion increases after revascularization of a chronic total ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback